Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1302
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00126191 | Intensive Chemotherapy and Rituximab in the Treatment of Burkitt Lymphoma | ||
| NCT06945120 | ACT Lung Health Intervention: Phase Two | ||
| NCT02135133 | A Study of Idelalisib (GS1101, CAL101) + Ofatumumab in Previously Untreated CLL/SLL | ||
| NCT00476177 | Donor Dendritic Cells And Donor Lymphocytes in Patients With Relapsed Hematologic Malignancies After Allogeneic Transplant | ||
| NCT03101254 | LY3022855 With BRAF/MEK Inhibition in Patients With Melanoma | ||
| NCT00681694 | Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer | ||
| NCT00004081 | Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer | ||
| NCT03057145 | Combination Study of Prexasertib and Olaparib in Patients With Advanced Solid Tumors | ||
| NCT04855695 | Avo In R/R And Previously Untreated MCL | ||
| NCT04930783 | NeoVax + CDX-301 and Nivolumab or Pembrolizumab in Melanoma | ||
| NCT04007588 | A Phase II Trial of Neoadjuvant Treatment With PD-1 Inhibition (Nivolumab) With or Without IDO Inhibition (BMS-986205) and With or Without CTLA-4 Inhibition (Ipilimumab) in Resectable Stage III or IV Melanoma | ||
| NCT03051672 | Phase II PEMBROLIZUMAB + PALLIATIVE RADIOTHERAPY IN BC | ||
| NCT04273139 | Ibrutinib + Venetoclax in Untreated WM | ||
| NCT00542451 | Adjuvant Paclitaxel and Trastuzumab for Node-Negative HER2-Positive Breast Cancer | ||
| NCT00516165 | RAD001 in Advanced Hepatocellular Carcinoma | ||
| NCT02117336 | Clinical Study of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) | ||
| NCT00880334 | Randomized Study of Docetaxel +/- Vandetanib in Metastatic TCC | ||
| NCT01228435 | IPI-504 in NSCLC Patients With ALK Translocations | ||
| NCT00658411 | Deferoxamine for Iron Overload Before Allogeneic Stem Cell Transplantation | ||
| NCT02653755 | The PRECISION Trial (Profiling Early Breast Cancer for Radiotherapy Omission): A Phase II Study of Breast-Conserving Surgery Without Adjuvant Radiotherapy for Favorable-Risk Breast Cancer | ||
| NCT02795858 | A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors | ||
| NCT02523040 | Lenalidomide for Adult Histiocyte Disorders | ||
| NCT06318871 | Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma | ||
| NCT01551693 | STA-9090(Ganetespib) in Patients With Unresectable Stage III or Stage IV Melanoma | ||
| NCT03414684 | Carboplatin +/- Nivolumab in Metastatic Triple Negative Breast Cancer | ||
| NCT04188535 | Serial MRI Scans During Radiation Therapy | ||
| NCT02355340 | Bone Mineral Density Status in Pediatric and Adolescent Survivors of Childhood Cancer With History of Bone Fracture | ||
| NCT04843904 | Safe Accelerated Venetoclax Escalation in CLL | ||
| NCT03244826 | Shared Care: Patient-Centered Management After Hematopoietic Cell Transplantation | ||
| NCT00095836 | Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy | ||
| NCT00165139 | Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and Sarcomas | ||
| NCT05796570 | A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies | ||
| NCT03717402 | Smartphone Technology to Alleviate Malignant Pain (STAMP) | ||
| NCT03586453 | Osimertinib In EGFR Mutant Lung Cancer | ||
| NCT00280930 | Letrozole in Postmenopausal Women at Increased Risk for Breast Cancer | ||
| NCT02909777 | Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma | ||
| NCT05783596 | Glofit and Obin in Follicular Lymphoma and Marginal Zone Lymphoma | ||
| NCT00142428 | Cetuximab in Patients With Unresectable or Metastatic Hepatocellular Carcinoma | ||
| NCT04947917 | Axillary Lymph Node Tattoo Marking Study | ||
| NCT00005988 | Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous Therapy | ||
| NCT04448886 | Sacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBC | ||
| NCT00215046 | Vinblastine and Methotrexate in Children With Pulmonary Vein Stenosis | ||
| NCT02113878 | Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck | ||
| NCT06888089 | Deep Clinical Trajectory Modeling to Optimize Accrual to Cancer Clinical Trials | ||
| NCT01753089 | Dendritic Cell Activating Scaffold in Melanoma | ||
| NCT01027910 | PCI-24781 in Combination With Doxorubicin to Treat Sarcoma | ||
| NCT00928018 | Tacrolimus/Sirolimus/Methotrexate vs Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic Stem Cell Transplantation for Patients With Lymphoma | ||
| NCT01078974 | Pomalidomide, Dexamethasone and Rituximab in Waldenstrom's Macroglobulinemia | ||
| NCT06152809 | CIML NK Cells With Venetoclax for AML | ||
| NCT06650514 | A Phase 2 Pilot Study to Evaluate the Safety and the Anti-Tumour Activity of the Myc Inhibitor OMO-103 Administered Intravenously in Patients With Advanced High-Grade Osteosarcoma |
